The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 8th 2025
The fixed-dose combination yielded a 49% greater reduction in low density lipoprotein cholesterol (LDL-C) compared with placebo.
Michigan Introduces Legislation Targeting Opioid Overprescribing
November 11th 2016On November 10, 2016, Michigan State Representatives introduced HB 6045, which would amend the Michigan Public Health Code to provide restrictions on the quantity of prescription opioid medications that can be issued by a prescriber under certain circumstances. This legislation comes on the heels of recent efforts by the CDC to raise awareness and hopefully curtail the growing opioid epidemic.
Read More
RxGenomix to Offer a Training Program in Pharmacogenomics
November 11th 2016Today, RxGenomix is pleased to announce that the American Pharmacists Association (APhA) will provide continuing pharmacy education credit for its training program in Pharmacogenomics, offering nearly 300,000 registered pharmacists access to education on the rapidly advancing science of pharmacogenomics.
Read More
After discussing the Basics of Accountable Care Organizations and Medication Therapy Management and Annual Wellness Visit services, the third and last section of the Pharmacists in ACOs series will focus on 3 more integration strategies for pharmacists within the ACO setting, including chronic care management, chronic disease state management, and transitions of care.
Read More
Hy-Vee Customers Donate Nearly $140,000 Over Four Days to Slain Police Officers' Families
November 9th 2016Hy-Vee, Inc. has thanked its customers for showing their respect and gratitude to slain Urbandale Police Officer Justin Martin and Des Moines Police Sgt. Anthony Beminio by donating nearly $140,000 to their families.
Read More
Equashield Surpasses 500 US Customers, Sees Sales Increase of 70% in Q3 of 2016
November 7th 2016Equashield has announced that, as of the end of the third quarter of 2016, it has surpassed 500 customers in the United States, indicative of the market’s preference for the company’s Equashield device.
Read More